Skip to main content
. 2022 Jun 3;12:908907. doi: 10.3389/fonc.2022.908907

Figure 2.

Figure 2

Kaplan-Meier analysis for OS in patients with hilar cholangiocarcinoma.(A) OS for patients with different levels of NMR. (B) OS for patients with different levels of LMR. (C) OS for patients with different levels of PLR. (D) OS for patients with different levels of tumor-infiltrating CD3+T cells infiltration. (E) OS for patients with different levels of tumor-infiltrating CD8+T cells infiltration. (F) OS for patients with different levels of tumor-infiltrating CD4+T cells infiltration.